Correlation Between Summit Therapeutics and SkyWest

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and SkyWest at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and SkyWest into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and SkyWest, you can compare the effects of market volatilities on Summit Therapeutics and SkyWest and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of SkyWest. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and SkyWest.

Diversification Opportunities for Summit Therapeutics and SkyWest

-0.58

Correlation Coefficient

Summit Therapeutics  SkyWest

Excellent diversification

The 3 months correlation between Summit and SkyWest is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and SkyWest in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SkyWest and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with SkyWest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SkyWest has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and SkyWest go up and down completely randomly.

Pair Corralation between Summit Therapeutics and SkyWest

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to under-perform the SkyWest. In addition to that, Summit Therapeutics is 2.38 times more volatile than SkyWest. It trades about -0.07 of its total potential returns per unit of risk. SkyWest is currently generating about 0.19 per unit of volatility. If you would invest  8,189  in SkyWest on September 20, 2024 and sell it today you would earn a total of  2,144  from holding SkyWest or generate 26.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Summit Therapeutics PLC  vs.  SkyWest

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

SkyWest

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in SkyWest are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, SkyWest showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Summit Therapeutics and SkyWest

The main advantage of trading using opposite Summit Therapeutics and SkyWest positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, SkyWest can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SkyWest will offset losses from the drop in SkyWest's long position.

The idea behind Summit Therapeutics PLC and SkyWest pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.